The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 5000 | 2018 |
Comprehensive molecular profiling of lung adenocarcinoma. CGAR Network | 4091* | 2014 |
Comprehensive genomic characterization of head and neck squamous cell carcinomas TCGA Network Nature, 2015 | 3490 | 2015 |
Oncogenic signaling pathways in the cancer genome atlas F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ... Cell 173 (2), 321-337. e10, 2018 | 2829 | 2018 |
Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 2408 | 2018 |
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ... Cell 173 (2), 291-304. e6, 2018 | 2272 | 2018 |
Comprehensive and integrative genomic characterization of hepatocellular carcinoma A Ally, M Balasundaram, R Carlsen, E Chuah, A Clarke, N Dhalla, RA Holt, ... Cell 169 (7), 1327-1341. e23, 2017 | 2090 | 2017 |
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1 N Agrawal, MJ Frederick, CR Pickering, C Bettegowda, K Chang, RJ Li, ... Science 333 (6046), 1154-1157, 2011 | 2080 | 2011 |
Machine learning identifies stemness features associated with oncogenic dedifferentiation TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ... Cell 173 (2), 338-354. e15, 2018 | 1835 | 2018 |
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma Skoulidis F, et al Cancer Discov, 2018 | 1395 | 2018 |
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade. Wei SC, Levine JH, Cogdill AP, Zhao Y, Anang NAS, Andrews MC, Sharma P, Wang ... Cell, 2017 | 1278 | 2017 |
Integrated genomic and molecular characterization of cervical cancer. CGAR Network Nature, 2017 | 1187* | 2017 |
An epithelial–mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor … LA Byers, L Diao, J Wang, P Saintigny, L Girard, M Peyton, L Shen, Y Fan, ... Clinical cancer research 19 (1), 279-290, 2013 | 1066 | 2013 |
Genomic and functional approaches to understanding cancer aneuploidy AM Taylor, J Shih, G Ha, GF Gao, X Zhang, AC Berger, SE Schumacher, ... Cancer cell 33 (4), 676-689. e3, 2018 | 984 | 2018 |
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression. Nat Commun, 2014 | 977* | 2014 |
Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas CGAR Network Cell, 2017 | 918 | 2017 |
Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities. F Skoulidis, LA Byers, L Diao, VA Papadimitrakopoulou, P Tong, Izzo, ... Cancer Discovery 5, 860-77, 2015 | 860 | 2015 |
Pathogenic germline variants in 10,389 adult cancers K Huang, RJ Mashl, Y Wu, DI Ritter, J Wang, C Oh, M Paczkowska, ... Cell 173 (2), 355-370. e14, 2018 | 787 | 2018 |
Targeting DNA damage response promotes anti-tumor immunity through STING-mediated T-cell activation in small cell lung cancer Sen T, Rodriguez BL, Chen L, Della Corte C, Morikawa N, Fujimoto J, Cristea ... Cancer Discovery, 2019 | 722 | 2019 |
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines DL Ellrott K, Bailey MH, Saksena G, Covington KR, Kandoth C, Stewart C, Hess ... Cell Syst, 2018 | 721 | 2018 |